The pilot study: a novel transarterial chemoembolization using degradable starch microspheres for hepatocellular carcinoma

A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial

“…We designed a novel TAI using lipiodol and DSM for use in HCC patients, and reported the usefulness of this procedure [28]. In this study, we investigated the efficacy of this novel TAI using lipiodol and DSM in a prospective randomized trial (lipiodol vs. DSM vs. lipiodol ?…”

“…Given this background, we designed a novel TAI using lipiodol and DSM for use in HCC patients [28]. After a mixture of an anticancer agent and lipiodol is injected, DSM is administered until stasis or reflux of the arterial flow.…”

Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma

“…Therefore, we designed TAI using lipiodol and DSMs (Lip ? DSM-TAI) for use in HCC patients [20,21]. In the study reported here, we investigated the predictors influencing response and survival in HCC patients receiving Lip ?…”

“…Therefore, we designed a novel TAI using lipiodol and DSMs (Lip ? DSM-TAI) for use in HCC patients [20]. After the lipiodol emulsion is injected, DSMs are administered until stasis or reflux of the arterial flow.…”

Development of Microcapsules Containing Oil-Based Contrast Medium

“…Arterial embolization for hepatocellular carcinoma has been originally proposed by Yamada et al [1]. For this therapy, various kinds of obstructing materials, such as gelatin sponge, acrylic polymer matrices impregnated and embedded with porcine gelatin, PVA spheres, porous gelatin spheres, starch microspheres, chitosan microspheres have been developed [2][3][4][5]. Since these materials themselves do not absorb X-ray strongly, contrast media such as Lipiodol have been injected together with the materials to identify the extent of the obstructing region.…”